EXELIXIS INC (NASDAQ:EXEL) – A High Growth Momentum Stock with Strong Technical Setup

EXELIXIS INC (NASDAQ:EXEL) stands out as a high-growth momentum candidate with a solid technical setup, making it an interesting prospect for investors seeking both earnings momentum and favorable chart patterns. The company, focused on developing oncology treatments, has demonstrated strong financial performance alongside improving technical conditions.

Growth Momentum Highlights

• Earnings Growth: EXEL has delivered a remarkable 205.6% year-over-year EPS growth (TTM), with recent quarterly EPS growth at 175%.
• Sales Growth: Revenue growth remains strong at 24.5% (TTM), with recent quarterly sales up 30.6%.
• Profit Margins Expanding: The latest quarter’s profit margin reached 28.7%, up from 24.7% in the prior quarter.
• Positive Revisions: Analysts have raised next-year EPS estimates by 10.1% over the past three months.
• Consistent Earnings Beats: The company has surpassed EPS estimates in all of the last four quarters, with an average beat of 55.5%.

Technical Strength & Setup

EXEL scores a perfect 10 on ChartMill’s Technical Rating, reflecting a strong uptrend across short and long-term timeframes. Key technical observations:

• Trend Strength: Both short-term and long-term trends are positive, with the stock outperforming 94% of the market over the past year.
• Support Levels: Multiple support zones exist between $40.36 and $41.12, providing a clear stop-loss area.
• Setup Quality: With a Setup Rating of 7, EXEL is consolidating after recent gains, reducing volatility and improving breakout potential.
• Volume Surge: Trading volume has increased recently, indicating stronger interest in the stock.

For a deeper look at the technicals, review the full technical report.

Our High Growth Momentum Breakout Setups Screen lists more stocks with similar growth and technical characteristics, updated daily.

Disclaimer

This is not investment advice. The observations here are based on current data, but investors should conduct their own research before making decisions.